{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T01:29:54Z","timestamp":1782437394510,"version":"3.54.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T00:00:00Z","timestamp":1771113600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005760","name":"University of Gothenburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005760","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Proteom"],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Plasma and cerebrospinal fluid are complementary sources of biomarkers for neurodegenerative diseases. The wide dynamic range of protein abundances, particularly in plasma, hampers detection of low-abundance proteins. Depletion of high-abundance proteins and efficient enzymatic digestion can improve proteome coverage but must be carefully optimized for reproducibility, throughput, and cost-efficiency for use in large-scale clinical proteomic studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We developed a scalable sample preparation workflow for plasma and cerebrospinal fluid (CSF) that integrates depletion of high-abundance proteins, optimized digestion using Lys-C and trypsin, and compatibility with both label-free and tandem mass tag (TMTpro)-based quantification. Depletion was performed using a multi-affinity resin with immobilized antibodies targeting 14 high-abundance plasma proteins, which collectively constitute\u2009\u2248\u200995% of total plasma protein content. We systematically evaluated protein depletion and enzyme digestion conditions, and the effect of deoxycholate on digestion, monitoring the number of detectable proteins and the quantitation precision.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A resin-to-plasma ratio of \u2265\u200975 and a mixing speed of 900\u00a0rpm ensured complete and reproducible depletion. Depletion resulted in an increase in the number of identified proteins by ~\u200965% in CSF, and ~\u200980% in plasma, tripling the number of brain-enriched proteins, with maintained quantitative precision (median coefficient of variation (CV) for relative protein abundances\u2009&lt;\u200911%). A two-step digestion protocol using Lys-C\/trypsin followed by trypsin yielded the highest reproducibility and detectability in plasma. Adding the detergent deoxycholate to the samples had little effect in CSF and only marginally improved proteome coverage for plasma but decreased quantification precision and throughput. Technical replicates from a 528-sample clinical amyotrophic lateral sclerosis (ALS) cohort showed high reproducibility, with intra-sample CVs substantially lower than inter-individual variation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The sample preparation workflow described here enabled deep and reproducible proteome profiling of plasma and CSF in high-throughput formats and was found to be suitable for biomarker discovery in large clinical studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12014-026-09589-1","type":"journal-article","created":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T13:24:17Z","timestamp":1771161857000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Shake and bake: a robust and cost-effective proteomic sample preparation workflow for plasma and cerebrospinal fluid"],"prefix":"10.1186","volume":"23","author":[{"given":"John","family":"R\u00f6nnholm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Thorsell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Sihlbom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Dugom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Easton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Gobom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,15]]},"reference":[{"key":"9589_CR1","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/bs.acc.2022.09.006","volume":"112","author":"J Simr\u00e9n","year":"2023","unstructured":"Simr\u00e9n J, Elmgren A, Blennow K, Zetterberg H. Fluid biomarkers in Alzheimer\u2019s disease. Adv Clin Chem. 2023;112:249\u201381.","journal-title":"Adv Clin Chem"},{"key":"9589_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03831-3","author":"A Farinas","year":"2025","unstructured":"Farinas A, Rutledge J, Bot VA, Western D, Ying K, Lawrence KA, et al. Disruption of the cerebrospinal fluid\u2013plasma protein balance in cognitive impairment and aging. Nat Med. 2025. https:\/\/doi.org\/10.1038\/s41591-025-03831-3.","journal-title":"Nat Med"},{"issue":"1","key":"9589_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37685-5","volume":"14","author":"PK Eide","year":"2023","unstructured":"Eide PK, Lashkarivand A, Pripp A, Valnes LM, Hovd MH, Ringstad G, et al. Plasma neurodegeneration biomarker concentrations associate with glymphatic and meningeal lymphatic measures in neurological disorders. Nat Commun. 2023;14(1):2084.","journal-title":"Nat Commun"},{"issue":"6","key":"9589_CR4","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1038\/s41591-025-03622-w","volume":"31","author":"S Palmqvist","year":"2025","unstructured":"Palmqvist S, Warmenhoven N, Anastasi F, Pilotto A, Janelidze S, Tideman P, et al. Plasma phospho-tau217 for Alzheimer\u2019s disease diagnosis in primary and secondary care using a fully automated platform. Nat Med. 2025;31(6):2036\u201343.","journal-title":"Nat Med"},{"issue":"6","key":"9589_CR5","doi-asserted-by":"publisher","first-page":"e9356","DOI":"10.15252\/msb.20199356","volume":"16","author":"JM Bader","year":"2020","unstructured":"Bader JM, Geyer PE, M\u00fcller JB, Strauss MT, Koch M, Leypoldt F, et al. Proteome profiling in cerebrospinal fluid reveals novel biomarkers of alzheimer\u2019s disease. Mol Syst Biol. 2020;16(6):e9356.","journal-title":"Mol Syst Biol"},{"issue":"9","key":"9589_CR6","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1021\/acs.jproteome.4c00104","volume":"23","author":"B Ward","year":"2024","unstructured":"Ward B, Pyr dit Ruys S, Balligand J-L, Belkhir L, Cani PD, Collet J-F, et al. Deep plasma proteomics with data-independent acquisition: clinical study protocol optimization with a COVID-19 cohort. J Proteome Res. 2024;23(9):3806\u201322.","journal-title":"J Proteome Res"},{"issue":"1","key":"9589_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s43587-023-00550-7","volume":"4","author":"BM Tijms","year":"2024","unstructured":"Tijms BM, Vromen EM, Mjaavatten O, Holstege H, Reus LM, van der Lee S, et al. Cerebrospinal fluid proteomics in patients with Alzheimer\u2019s disease reveals five molecular subtypes with distinct genetic risk profiles. Nat Aging. 2024;4(1):33\u201347.","journal-title":"Nat Aging"},{"issue":"2","key":"9589_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/prca.202100010","volume":"16","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Zhang Y, Zhang J, Yang G. Plasma proteome profiling using tandem mass tag labeling technology reveals potential biomarkers for Parkinson\u2019s disease: a preliminary study. Proteomics Clin Appl. 2022;16(2):e2100010.","journal-title":"Proteomics Clin Appl"},{"issue":"14","key":"9589_CR9","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1002\/elps.200305909","volume":"25","author":"G Maccarrone","year":"2004","unstructured":"Maccarrone G, Milfay D, Birg I, Rosenhagen M, Holsboer F, Grimm R, et al. Mining the human cerebrospinal fluid proteome by immunodepletion and shotgun mass spectrometry. Electrophoresis. 2004;25(14):2402\u201312.","journal-title":"Electrophoresis"},{"issue":"3","key":"9589_CR10","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1093\/clinchem\/hvab202","volume":"68","author":"A Mc Ardle","year":"2022","unstructured":"Mc Ardle A, Binek A, Moradian A, Chazarin Orgel B, Rivas A, Washington KE, et al. Standardized workflow for precise Mid- and High-Throughput proteomics of blood biofluids. Clin Chem. 2022;68(3):450\u201360.","journal-title":"Clin Chem"},{"issue":"7","key":"9589_CR11","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1021\/acs.jproteome.9b00607","volume":"19","author":"S Zhang","year":"2020","unstructured":"Zhang S, Raedschelders K, Venkatraman V, Huang L, Holewinski R, Fu Q, et al. A dual workflow to improve the proteomic coverage in plasma using data-independent acquisition-MS. J Proteome Res. 2020;19(7):2828\u201337.","journal-title":"J Proteome Res"},{"issue":"4","key":"9589_CR12","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1074\/mcp.M500331-MCP200","volume":"5","author":"L Anderson","year":"2006","unstructured":"Anderson L, Hunter CL. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol Cell Proteom. 2006;5(4):573\u201388.","journal-title":"Mol Cell Proteom"},{"issue":"1","key":"9589_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17033-7","volume":"11","author":"JE Blume","year":"2020","unstructured":"Blume JE, Manning WC, Troiano G, Hornburg D, Figa M, Hesterberg L, et al. Rapid, deep and precise profiling of the plasma proteome with multi-nanoparticle protein corona. Nat Commun. 2020;11(1):3662.","journal-title":"Nat Commun"},{"key":"9589_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jprot.2025.105519","volume":"321","author":"K Roger","year":"2025","unstructured":"Roger K, Metatla I, Ceccacci S, Wahbi K, Mott\u00e9 L, Chhuon C, et al. Mining the plasma proteome: evaluation of enrichment methods for depth and reproducibility. J Proteomics. 2025;321:105519.","journal-title":"J Proteomics"},{"issue":"11","key":"9589_CR15","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1002\/pmic.200500614","volume":"6","author":"R Terracciano","year":"2006","unstructured":"Terracciano R, Gaspari M, Testa F, Pasqua L, Tagliaferri P, Cheng MM, et al. Selective binding and enrichment for low-molecular weight biomarker molecules in human plasma after exposure to nanoporous silica particles. Proteomics. 2006;6(11):3243\u201350.","journal-title":"Proteomics"},{"issue":"11","key":"9589_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2025.101071","volume":"24","author":"V Albrecht","year":"2025","unstructured":"Albrecht V, M\u00fcller-Reif JB, Brennsteiner V, Mann M. A simplified perchloric acid workflow with neutralization (PCA N) for democratizing deep plasma proteomics at population scale. Mol Cell Proteomics. 2025;24(11):101071.","journal-title":"Mol Cell Proteomics"},{"key":"9589_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2024.124046","volume":"1235","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Zheng H, Tan Z, Kang E, Xue P, Li X, et al. Optimizing and integrating depletion and precipitation methods for plasma proteomics through data-independent acquisition-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2024;1235:124046.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"4","key":"9589_CR18","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1021\/pr050415p","volume":"5","author":"A Zougman","year":"2006","unstructured":"Zougman A, Wi\u015bniewski JR. Beyond linker histones and high mobility group proteins: global profiling of perchloric acid soluble proteins. J Proteome Res. 2006;5(4):925\u201334.","journal-title":"J Proteome Res"},{"key":"9589_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2022.100279","author":"P Skowronek","year":"2022","unstructured":"Skowronek P, Thielert M, Voytik E, Tanzer MC, Hansen FM, Willems S, et al. Rapid and in-depth coverage of the (phospho-) proteome with deep libraries and optimal window design for dia-PASEF. Mol Cell Proteomics. 2022. https:\/\/doi.org\/10.1016\/j.mcpro.2022.100279.","journal-title":"Mol Cell Proteomics"},{"issue":"1","key":"9589_CR20","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13195-022-01113-5","volume":"14","author":"EB Dammer","year":"2022","unstructured":"Dammer EB, Ping L, Duong DM, Modeste ES, Seyfried NT, Lah JJ, et al. Multi-platform proteomic analysis of alzheimer\u2019s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisome. Alzheimers Res Ther. 2022;14(1):174.","journal-title":"Alzheimers Res Ther"},{"key":"9589_CR21","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1126\/sciadv.aaz9360","volume":"6","author":"L Higginbotham","year":"2020","unstructured":"Higginbotham L, Ping L, Dammer EB, Duong DM, Zhou M, Gearing M, et al. Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic alzheimer\u2019s disease. Sci Adv. 2020;6:43.","journal-title":"Sci Adv"},{"issue":"1","key":"9589_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-024-00429-6","volume":"13","author":"X Zhang","year":"2024","unstructured":"Zhang X, Wang J, Zhang Z, Ye K. Tau in neurodegenerative diseases: molecular mechanisms, biomarkers, and therapeutic strategies. Transl Neurodegener. 2024;13(1):40.","journal-title":"Transl Neurodegener"},{"issue":"1","key":"9589_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-025-00841-0","volume":"20","author":"S Weiner","year":"2025","unstructured":"Weiner S, Sauer M, Montoliu-Gaya L, Benedet AL, Ashton NJ, Gonzalez-Ortiz F, et al. Cerebrospinal fluid proteome profiling across the Alzheimer\u2019s disease continuum: a step towards solving the equation for \u2018X.\u2019 Mol Neurodegener. 2025;20(1):52.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"9589_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-021-00230-6","volume":"7","author":"E Giusto","year":"2021","unstructured":"Giusto E, Yacoubian TA, Greggio E, Civiero L. Pathways to Parkinson\u2019s disease: a spotlight on 14-3-3 proteins. NPJ Parkinsons Dis. 2021;7(1):85.","journal-title":"NPJ Parkinsons Dis"},{"issue":"7","key":"9589_CR25","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1093\/brain\/awae032","volume":"147","author":"J Nilsson","year":"2024","unstructured":"Nilsson J, Pichet Binette A, Palmqvist S, Brum WS, Janelidze S, Ashton NJ, et al. Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum of neurodegenerative diseases. Brain. 2024;147(7):2414\u201327.","journal-title":"Brain"},{"issue":"10","key":"9589_CR26","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","volume":"14","author":"M Khalil","year":"2018","unstructured":"Khalil M, Teunissen CE, Otto M, Piehl F, Sormani MP, Gattringer T, et al. Neurofilaments as biomarkers in neurological disorders. Nat Rev Neurol. 2018;14(10):577\u201389.","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"9589_CR27","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41591-024-03424-6","volume":"31","author":"RI Scahill","year":"2025","unstructured":"Scahill RI, Farag M, Murphy MJ, Hobbs NZ, Leocadi M, Langley C, et al. Somatic CAG repeat expansion in blood associates with biomarkers of neurodegeneration in Huntington\u2019s disease decades before clinical motor diagnosis. Nat Med. 2025;31(3):807\u201318.","journal-title":"Nat Med"},{"issue":"6220","key":"9589_CR28","doi-asserted-by":"publisher","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n M, Fagerberg L, Hallstr\u00f6m BM, Lindskog C, Oksvold P, Mardinoglu A, et al. Tissue-based map of the human proteome. Science. 2015;347(6220):1260419.","journal-title":"Science"},{"key":"9589_CR29","doi-asserted-by":"publisher","DOI":"10.1101\/2025.01.08.632035","author":"WF Beimers","year":"2025","unstructured":"Beimers WF, Overmyer KA, Sinitcyn P, Lancaster NM, Quarmby ST, Coon JJ. A technical evaluation of plasma proteomics technologies. bioRxiv. 2025. https:\/\/doi.org\/10.1101\/2025.01.08.632035.","journal-title":"bioRxiv"},{"issue":"1","key":"9589_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.xinn.2023.100544","volume":"5","author":"Q-Q Tao","year":"2024","unstructured":"Tao Q-Q, Cai X, Xue Y-Y, Ge W, Yue L, Li X-Y, et al. Alzheimer\u2019s disease early diagnostic and staging biomarkers revealed by large-scale cerebrospinal fluid and serum proteomic profiling. The Innovation. 2024;5(1):100544.","journal-title":"The Innovation"},{"issue":"11","key":"9589_CR31","doi-asserted-by":"publisher","first-page":"i","DOI":"10.1038\/nmeth.f.371","volume":"10","author":"S Saveliev","year":"2013","unstructured":"Saveliev S, Bratz M, Zubarev R, Szapacs M, Budamgunta H, Urh M. Trypsin\/Lys-C protease mix for enhanced protein mass spectrometry analysis. Nat Methods. 2013;10(11):i\u2013ii.","journal-title":"Nat Methods"},{"issue":"10","key":"9589_CR32","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1074\/mcp.M112.025585","volume":"12","author":"IR Le\u00f3n","year":"2013","unstructured":"Le\u00f3n IR, Schw\u00e4mmle V, Jensen ON, Sprenger RR. Quantitative assessment of in-solution digestion efficiency identifies optimal protocols for unbiased protein analysis. Mol Cell Proteomics. 2013;12(10):2992\u20133005.","journal-title":"Mol Cell Proteomics"}],"container-title":["Clinical Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12014-026-09589-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12014-026-09589-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12014-026-09589-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:17:30Z","timestamp":1781633850000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12014-026-09589-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,15]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["9589"],"URL":"https:\/\/doi.org\/10.1186\/s12014-026-09589-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8071230\/v1","asserted-by":"object"}]},"ISSN":["1542-6416","1559-0275"],"issn-type":[{"value":"1542-6416","type":"print"},{"value":"1559-0275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,15]]},"assertion":[{"value":"9 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Surplus volume from CSF and plasma samples from the Clinical Routine Neurochemistry Laboratory at the Sahlgrenska University Hospital were used for method development after de-identification to prevent that they can be traced back to an individual patient, in accordance with the Swedish Biobank law (Biobanks in Medical Care Act) and the Swedish ethical legislation (The Act concerning the Ethical Review of Research Involving Humans). CSF samples from the Target ALS foundation were collected in accordance with an informed consent procedure and subject to applicable ethical approvals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}